Navigation Links
Newer Blood Pressure Drugs Decrease Risk Of Diabetes

Patients taking newer blood pressure drugs have a decreased risk of developing diabetes, according to an analysis of the biggest clinical trial in Europe. The study found that// only 8 percent of the people on newer medicines developed diabetes as against 11.4 percent of those on older drugs.

The study involved 19,000 people. The study compared drugs like Norvasc and Coversyl with a beta-blocker and a diuretic. Norvasc is amlodipine, while Coversyl is perindopril. Professor Peter Sever of Imperial College in London, co-chairman of the study, said the findings underlined the fact that beta-blockers were no longer effecting in treating blood pressure.
RAS
'"/>




Page: 1

Related medicine news :

1. The Efficacy Of Newer Stents Questioned
2. Newer Generation Sleeping Pills Lack Superior Performance
3. Autoimmune Diseases – Newer Preventive Measure
4. Need for Newer AIDS Drugs In China
5. Newer Antidepressants May Trigger Violent Behavior
6. Newer Class of Antidepressants Similar in Effectiveness, Side Effects Differ
7. Study Sheds Light on Value of Newer Antipsychotic Drugs for Schizophrenia
8. Cellulose Nanocrystal Research Paves the Way for Newer Vaccines, Computer Inks
9. Recommendations for Treatment of Blood Pressue
10. Blood Cells Capable of Regenerating Liver
11. Blood clots likely in long travel
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... whiteboard display solutions, proudly announced today that a new solution for Emergency Departments ... fit in the tight space in Emergency Department examination rooms, and with a ...
(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 ... ... the Workers Compensation Research Institute (WCRI) officially opened registration today for its ... Place Hotel in Boston, MA . , The theme of the conference is ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading digital ... aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media ... Jr said, “CURE Media Group is honored to team up with Upstage Lung Cancer ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged ... in mind, SIGVARIS has created a new line of anti-embolism stockings to help ... provide the benefits of graduated compression when transitioning from recovery to early rehabilitation. ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016 KEY FINDINGS ... of the market in 2016 and is expected to ... attributed to a large number of surgical procedures that ... largest share in the patient temperature management market.) Patient ... reducing loss of blood during surgeries, lowering the risks ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology: